CLSD – clearside biomedical, inc. (US:NASDAQ)
Stock Stats
News
Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on Thursday, May 9, 2024 [Yahoo! Finance]
Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on Thursday, May 9, 2024
Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors [Yahoo! Finance]
Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $4.00 price target on the stock.
Form ARS Clearside Biomedical, For: Dec 31
Form DEFA14A Clearside Biomedical,
Form DEF 14A Clearside Biomedical, For: Jun 20
Form 4 Clearside Biomedical, For: Apr 17 Filed by: Gibney Anthony S
Form 4 Clearside Biomedical, For: Apr 15 Filed by: Gibney Anthony S
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.